Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Current Deferred Revenue (2018 - 2022)

Historic Current Deferred Revenue for Zai Lab (ZLAB) over the last 5 years, with Q1 2022 value amounting to $26.9 million.

  • Zai Lab's Current Deferred Revenue rose 6146.97% to $26.9 million in Q1 2022 from the same period last year, while for Mar 2022 it was $26.9 million, marking a year-over-year increase of 6146.97%. This contributed to the annual value of $27.5 million for FY2021, which is 6304.43% up from last year.
  • As of Q1 2022, Zai Lab's Current Deferred Revenue stood at $26.9 million, which was up 6146.97% from $27.5 million recorded in Q4 2021.
  • In the past 5 years, Zai Lab's Current Deferred Revenue registered a high of $27.5 million during Q4 2021, and its lowest value of $2.1 million during Q4 2018.
  • In the last 5 years, Zai Lab's Current Deferred Revenue had a median value of $17.2 million in 2020 and averaged $16.0 million.
  • As far as peak fluctuations go, Zai Lab's Current Deferred Revenue soared by 3958.33% in 2019, and later soared by 48514.4% in 2020.
  • Over the past 5 years, Zai Lab's Current Deferred Revenue (Quarter) stood at $2.1 million in 2018, then soared by 39.58% to $2.9 million in 2019, then surged by 485.14% to $16.9 million in 2020, then surged by 63.04% to $27.5 million in 2021, then dropped by 2.15% to $26.9 million in 2022.
  • Its last three reported values are $26.9 million in Q1 2022, $27.5 million for Q4 2021, and $17.5 million during Q3 2021.